Skip to content
October 8, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Global Breast Cancer Awareness
  • Navigating the Post-Treatment Journey: Breast Cancer Canada’s October Education Series
  • Global Breast Cancer Awareness

Navigating the Post-Treatment Journey: Breast Cancer Canada’s October Education Series

Basiran October 7, 2026 7 minutes read
navigating-the-post-treatment-journey-breast-cancer-canadas-october-education-series-2

As the landscape of oncology continues to evolve, the transition from active cancer treatment to long-term survivorship remains a critical, yet often daunting, phase for patients. For those diagnosed with HR+/HER2- early breast cancer, the journey does not simply end when the final infusion or radiation session is complete. Recognizing this, Breast Cancer Canada (BCC) has launched a comprehensive October Education Series designed to empower patients with evidence-based information, practical tools, and emotional support.

From understanding the complexities of recurrence risk to reclaiming physical and emotional well-being, this series serves as a vital resource for the thousands of Canadians navigating life after a breast cancer diagnosis.


The Core of Survivorship: Understanding Recurrence Risk

The October series kicked off on October 1, 2026, with an in-depth presentation by Dr. Nathalie Levasseur, a prominent medical oncologist at BC Cancer. The session, titled "Risk of Recurrence," addressed one of the most pressing concerns for patients with HR+/HER2- breast cancer: the uncertainty of what lies ahead.

Clinical and Pathological Insights

Dr. Levasseur emphasized that recurrence risk is not a one-size-fits-all metric. It is a nuanced calculation based on a combination of clinical factors—such as tumor size, nodal involvement, and grade—and pathological markers. However, the modern approach to oncology now integrates advanced genomic testing. By analyzing the genetic signature of a tumor, clinicians can provide a more personalized risk assessment, allowing for tailored treatment plans that avoid both over-treatment and under-treatment.

The Role of Systemic Therapy

A significant portion of the discussion focused on the evolving treatment landscape. Dr. Levasseur detailed the current standards of care, including the pivotal roles of endocrine therapy and CDK4/6 inhibitors. These treatments have significantly altered the prognosis for many, yet they bring their own set of challenges. Dr. Levasseur encouraged patients to maintain an open dialogue with their care teams, providing a roadmap of questions to help patients advocate for themselves during follow-up appointments.

Addressing the Psychological Burden

Perhaps the most poignant part of the session was the discussion surrounding the "fear of recurrence." Even with favorable clinical data, the psychological weight of potential relapse can hinder a survivor’s quality of life. Dr. Levasseur acknowledged that uncertainty is a persistent component of survivorship and provided strategies for managing "scanxiety" and the existential questions that often arise in the years following active treatment.

For those who missed the live event, a recording of the session and the accompanying presentation slides are available via the Breast Cancer Canada portal.


Chronology of the October Education Series

Breast Cancer Canada has structured its October programming to follow a logical progression, mirroring the stages of a patient’s post-treatment recovery—from biological health to physical restoration and, finally, emotional realignment.

  • October 1: Risk of Recurrence with Dr. Nathalie Levasseur. Focus: Medical management and risk assessment.
  • October 8: Nutrition After Breast Cancer with Jean LaMantia, RD. Focus: Biological health, muscle maintenance, and evidence-based dietary habits.
  • October 15: Living Well: Physical Effects Beyond Treatment with Voula Pantelis. Focus: Managing the lingering physical aftermath of surgery and systemic therapy.
  • October 22: Moving Emotions Forward: Root to Rise with Jacqueline Beatty. Focus: Mental health, identity, and transitioning back into daily life.

Supporting Data: The Importance of Evidence-Based Survivorship

In the age of social media, cancer survivors are often bombarded with conflicting, and sometimes harmful, advice. The upcoming sessions in the BCC series aim to cut through this noise by grounding all guidance in clinical research.

Nutrition as a Tool for Recovery

On October 8, Jean LaMantia, a registered dietitian and cancer survivor, will address the overwhelming nature of cancer-related nutrition. The session is built on the premise that "more is not always better." LaMantia will focus on:

  • Protein and Muscle Maintenance: Essential for counteracting the effects of muscle-wasting during long-term treatments.
  • Bone Health: A critical consideration for patients on endocrine therapy, which can impact bone density.
  • Gut Health: Exploring the link between the microbiome and long-term wellness.
  • Myth-Busting: Providing a rigorous defense against fad diets that often lack scientific backing.

Managing Persistent Physical Changes

The session on October 15, led by Voula Pantelis of AMOENA Canada, shifts the focus to the body’s physical recovery. Many patients report that their bodies feel like "strangers" after treatment. Pantelis will cover practical management strategies for:

  • Scar Tissue and Lymphedema: Techniques for physical maintenance that improve mobility and comfort.
  • Body Image: Navigating the changes in physical appearance and how to approach intimacy and self-acceptance.
  • Daily Functionality: Practical advice on everything from travel accommodations to returning to exercise routines.

Official Perspectives: Empowering the Patient Voice

The inclusion of both medical professionals and patient advocates in this series is intentional. By bridging the gap between clinical expertise and lived experience, Breast Cancer Canada is fostering an environment where patients feel heard and validated.

The "Root to Rise" Philosophy

The series concludes on October 22 with an exploration of the emotional aftermath of cancer. Jacqueline Beatty’s "Root to Rise" framework represents a shift toward holistic survivorship. As Beatty notes, the transition back to "normalcy" is often the most difficult stage. Many survivors grapple with:

  • Identity Reconfiguration: Who am I now that the "patient" label is being removed?
  • Boundary Setting: Learning to say no to demands that no longer align with one’s new priorities.
  • Relational Dynamics: Re-navigating family and work roles that may have shifted significantly during the treatment period.

This session is designed not just to provide coping mechanisms, but to help survivors actively design a life that honors their experiences while allowing them to move forward with purpose.


Implications for the Future of Cancer Care

The BCC October series reflects a broader trend in oncology: the shift toward "patient-centered survivorship." Historically, cancer research and care delivery focused heavily on the acute phase—diagnosis, surgery, chemotherapy, and radiation. However, as survival rates improve, the focus is necessarily widening to include the decades that follow treatment.

The Need for Long-Term Support

The implications of these sessions are clear: medical treatment is only one pillar of recovery. A truly comprehensive approach requires a multidisciplinary strategy that includes nutritional counseling, physical rehabilitation, and psychological support.

Bridging the Knowledge Gap

By providing these webinars, Breast Cancer Canada is addressing a significant gap in the healthcare system. Many primary care physicians are not equipped to provide specialized advice on the specific nutritional or physical concerns of breast cancer survivors. By hosting these sessions, BCC is creating a standardized, reliable knowledge base that empowers patients to take an active role in their own long-term health.

Cultivating Community

Beyond the information provided, the series serves as a vital community hub. The act of sharing these experiences—the fears, the physical discomforts, and the emotional hurdles—reduces the isolation that often accompanies a cancer diagnosis. Participants are not just learning facts; they are connecting with others who understand the unique vocabulary of the cancer experience.

Conclusion

As we look toward the remainder of October 2026, the series stands as a testament to the resilience of the breast cancer community. Whether it is a patient newly finished with treatment or someone years into their journey, these sessions offer the tools needed to move from a state of "surviving" to a state of "thriving."

Breast Cancer Canada continues to set the gold standard for patient advocacy, ensuring that no one has to navigate the complex road of post-treatment life alone. For those looking to participate, registration for the remaining sessions is currently open, and the resources provided will undoubtedly serve as a cornerstone for patient well-being in the months and years to come.

About the Author

Basiran

Author

View All Posts

Post navigation

Previous: Beyond the Pink: Demanding Transparency and Impact in Breast Cancer Awareness Campaigns
Next: Research Over Ribbons: BCRF Transforms Grand Central Into a Hub for Breast Cancer Science

Related Stories

strengthening-the-global-health-shield-dr-tedross-landmark-state-visit-to-jordan
  • Global Breast Cancer Awareness

Strengthening the Global Health Shield: Dr. Tedros’s Landmark State Visit to Jordan

Evan Lee Salim October 7, 2026
bridging-the-disparity-new-national-survey-calls-for-a-unified-standard-of-breast-cancer-care-in-canada
  • Global Breast Cancer Awareness

Bridging the Disparity: New National Survey Calls for a Unified Standard of Breast Cancer Care in Canada

Sagoh October 7, 2026
global-health-solidarity-who-director-general-strengthens-strategic-ties-with-jordan-amid-regional-crisis
  • Global Breast Cancer Awareness

Global Health Solidarity: WHO Director-General Strengthens Strategic Ties with Jordan Amid Regional Crisis

Pevita Pearce October 7, 2026

Recent Posts

  • Unveiling a Cunning Cancer Strategy: How Triple-Negative Breast Cancer Recruits Nerves for Growth and Survival
  • ArriVent’s Firmonertinib Fails to Meet Primary Endpoint in NSCLC Trial, Stock Plummets Amidst Competitive Landscape
  • Navigating the Intersection: GLP-1 Medications and Breast Cancer – What the Latest Research Reveals
  • Research as the Cure: BCRF Transforms Grand Central Terminal into a Hub of Hope and Science
  • Strengthening the Lifeline: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership Amid Crisis

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unveiling-a-cunning-cancer-strategy-how-triple-negative-breast-cancer-recruits-nerves-for-growth-and-survival
  • Medical Research and Clinical Trials

Unveiling a Cunning Cancer Strategy: How Triple-Negative Breast Cancer Recruits Nerves for Growth and Survival

Iffa Jayyana October 7, 2026
arrivents-firmonertinib-fails-to-meet-primary-endpoint-in-nsclc-trial-stock-plummets-amidst-competitive-landscape
  • Medical Research and Clinical Trials

ArriVent’s Firmonertinib Fails to Meet Primary Endpoint in NSCLC Trial, Stock Plummets Amidst Competitive Landscape

Muslim October 7, 2026
navigating-the-intersection-glp-1-medications-and-breast-cancer-what-the-latest-research-reveals
  • Patient Advocacy and Support

Navigating the Intersection: GLP-1 Medications and Breast Cancer – What the Latest Research Reveals

Ammar Sabilarrohman October 7, 2026
research-as-the-cure-bcrf-transforms-grand-central-terminal-into-a-hub-of-hope-and-science
  • Patient Advocacy and Support

Research as the Cure: BCRF Transforms Grand Central Terminal into a Hub of Hope and Science

Siti Muinah October 7, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.